Medicine & Health

WashU Medicine researchers have identified a promising approach to treat myeloproliferative neoplasms, a group of chronic blood cancers, by interfering with a protein that drives inflammation.

A grant to WashU Medicine researchers will fund the study of how inflammation drives myeloproliferative neoplasms, a group of blood cancers at high risk of progressing to acute myeloid leukemia.

Adults with a history of cancer are less likely to be physically active than those without a cancer history, finds a new study from Washington University in St. Louis.

The extent of tumor clearance and timing of treatment are important factors that help improve survival, according to a large analysis of patient outcomes by researchers at WashU Medicine.

WashU Medicine researchers have found that cells originating in bone and normally involved in bone formation are recruited to primary breast tumors, where they become part of the tumor microenvironment and may play a role in supporting tumor growth.

WashU Medicine researchers discovered that while rates of mammography screening remained steady in the overall population over two decades, they fell significantly among younger white women, uninsured women and current smokers.

WashU Medicine researchers have developed a technique to synthesize shape-shifting “disordered proteins,” creating new opportunities to understand the basis of disease and design potential medical interventions.

Biomedical engineers at WashU have created a new platform to study mechanobiology, which can help with research on cancer and fibrosis.

Yin Cao, ScD, an associate professor in the Division of Public Health Sciences in the WashU Medicine Mary Culver Department of Surgery, has been named a 2026 Fellow of the 101st class of the John Simon Guggenheim Memorial Foundation.

WashU Medicine researchers have shown in mice that a medication-design technique in which modular components of anti-cancer drugs are administered separately and assembled in the body — using what’s known as “click chemistry” — is more effective than standard treatments at targeting and shrinking tumors.